Breaking News

Heat Biologics to Build New Biodefense Biologics Manufacturing Facility

To operate as a full-service CDMO to provide third-party manufacturing services.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Heat Biologics, Inc., a clinical-stage biopharmaceutical company focused on developing novel biodefense assets and therapies to modulate the immune system, has planned a development partnership for its Scorpion Biological Services subsidiary with a private developer, the State of Kansas and local and university affiliates, to support the development of a new biodefense-focused large molecule and biologics biomanufacturing facility in Manhattan, KS. Manhattan is the home of Kansas State Universit...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters